Introduction
============

The Kraepelinian dichotomy between schizophrenia and bipolar disorder, otherwise classically referred to dementia praecox and manic-depressive insanity respectively, has sustained a recent and vigorous onslaught (Heckers, [@B55]). This debate echoes Kraepelin\'s own prescient observation that ''No experienced psychiatrist will deny that there is an alarmingly large number of cases in which it seems impossible, in spite of the most careful observation, to make a firm diagnosis''(Angst and Gamma, [@B6]). Increasingly, the lines of scientific evidence converge toward dimensional constructs or fused constructs, as opposed to purely categorical ones. The rationale for this is that diagnostic classifications make *a priori* assumptions about the illness entity, precluding a truly heuristic approach to etiological and treatment advances. For example, researchers typically compare a group of patients with bipolar disorder or schizophrenia with healthy controls and adopt a disease classification system such as ICD10 or DSM IV. However, both conditions are intimately related, with shared genetic determinants (Lichtenstein et al., [@B82]) and common polygenic variants, as confirmed by the International Schizophrenia Consortium (ISC) in a genome-wide association study of 3,322 Europeans (International Schizophrenia Consortium et al., [@B63]). Thus, epidemiological characteristics, family studies, and overlapping genetic linkages together support shared genetic risk factors in bipolar and schizophrenia (Berrettini, [@B12]) and there is additional new evidence showing similar changes in gene expression in both conditions (Shao and Vawter, [@B111]). Llewellyn ([@B84]) has suggested that bipolar disorder is in fact part and parcel of schizophrenia and constitutes an "autopoietic response" to restore order in schizophrenics (Llewellyn, [@B84]). The opposing position is that bipolar disorder and schizophrenia are separate disorders which happen to trigger the same, general cognitive deficits (Bora et al., [@B14]).

Neuroimaging studies of schizophrenia and bipolar disorder typically provide considerable data on the brain endophenotype of psychosis. However the extent to which bipolar disorder is considered separately from schizophrenia and other psychoses varies. For example, schizophrenia usually includes psychotic symptoms such as hallucinations, delusions, and thought disorder, as well as "negative" symptoms such as flatness of affect, poverty of speech, or loss of motivation. The diagnosis of schizophrenia excludes significant mood disorder. In contrast bipolar disorder is characterized by prominent mood symptoms and may or may not involve psychosis. Brain imaging studies in schizophrenia generally report lower brain volume, lateral ventricular enlargement, frontal, and lower volumes in temporal, limbic, and subcortical regions (Chua and McKenna, [@B22]; Gur et al., [@B50]; McCarley et al., [@B91]; Wright et al., [@B135]; Chua et al., [@B20]) and meta-analyses of "voxel-based morphometry" (VBM) studies which quantify brain differences at each voxel or "volume element" in brain, confirm fronto-striatal temporal and insula deficits are already evident at first presentation of schizophrenia (Ellison-Wright et al., [@B39]; Chan et al., [@B18]; Leung et al., [@B80]). Some groups report brain differences that appear to be specific to schizophrenia (Harvey et al., [@B54]; Pearlson et al., [@B103]; Zipursky et al., [@B141]; Altshuler et al., [@B4]; Hirayasu et al., [@B59]; McDonald et al., [@B92]), while others find similar changes in bipolar disorder and schizophrenia (Friedman et al., [@B44]; Lim et al., [@B83]; Velakoulis et al., [@B127]; Janssen et al., [@B64]).

The literature is complicated by issues of sample heterogeneity and study design. In some studies the conditions have been examined together as a generic psychosis category (McIntosh et al., [@B93], [@B94]; McDonald et al., [@B92]; Janssen et al., [@B64]), with diagnostic categories explored *post-hoc*. For example, Janssen et al. ([@B64]) found left medial frontal gray matter deficits in both conditions with left middle frontal deficits only in schizophrenia (Janssen et al., [@B64]). Others have separately compared schizophrenia and bipolar groups with neurotypical controls and reported an extensive system of gray matter deficits through fronto-temporal-thalamic and cerebellar regions in schizophrenia, and no significant gray matter abnormalities in the bipolar group (McDonald et al., [@B92]). Most recently, Bora et al. ([@B13]), conducted a meta-analysis on Bipolar Disorder using signed differential mapping (Bora et al., [@B13]), an alternative voxel-based meta-analytic approach designed to represent both positive and negative differences in the same summary map. They found the condition involved anatomical differences compared to controls in bilateral insula, inferior frontal, and left anterior cingulate, and their results mostly coincided with another meta-analysis conducted by Ellison-Wright and Bullmore ([@B38]) using anatomical likelihood estimation (ALE) to qualitatively compare gray matter differences in schizophrenia and bipolar disorders relative to controls (Ellison-Wright and Bullmore, [@B38]). In the latter study lower gray matter volume in anterior cingulate and insular regions overlapped when the meta-analysis summary map from studies comprising a total 2,058 patients with schizophrenia was overlaid on the meta-analysis summary map generated from studies of a total 366 patients with bipolar disorder. This pattern was retained when a subsample analysis of 13 studies of both conditions were analyzed and provided a good description of areas commonly affected by schizophrenia. Although gender balance was attempted in this sub-analysis, other confounders such as illness chronicity and age may also have affected the results. Moreover, what is missing from the literature is an estimation of the *extent* to which brain regions implicated in either disorder, are more likely to be affected by schizophrenia or bipolar disorder.

A recognized difficulty with the neuroimaging literature has been the many more VBM studies of schizophrenia than bipolar disorder published (Ellison-Wright and Bullmore, [@B38]). Since the initial meta-analyses of voxel-based studies of bipolar disorder were carried out, a number of new studies on bipolar disorder have been published, substantially increasing the number of bipolar patients sampled. This offers a timely opportunity to carry out a meta-analysis which quantifies the likelihood that schizophrenia or bipolar disorder is responsible for differences in regional brain anatomy. To prevent schizophrenia studies biasing the analysis, and to attempt to minimize confounders, a one-on-one matching approach was adopted to pair up individual bipolar studies with a corresponding schizophrenia study. The matching variables used were duration of illness, mean age of patients, mean age of control, number of patients, and number of controls.

Anatomical likelihood estimation was introduced by Turkeltaub et al. ([@B124]) as "Activation Likelihood Estimation", in which it was used to study the functional neuroanatomy of single-word reading in healthy individuals. Despite bearing different nomenclature, ALE and Activation Likelihood Estimation share the same statistical approach. Essentially, in activation likelihood estimation, the data entered into analyses are of significant BOLD activation, whereas in anatomical likelihood they concern significant volume differences.

Materials and Methods
=====================

Data search
-----------

A search was carried out using Pubmed, Scopus, and PsycINFO databases with the keywords: bipolar, MRI, VBM, voxel, voxel based morphometry, and statistical parametric mapping (SPM). A branch search was conducted from the retrieved studies. Studies comparing groups with bipolar patients, to controls balanced for IQ, gender, and handedness were selected. The studies must have been peer-reviewed and published in the English language. Moreover, they must have used voxel-based imaging methods, and reported co-ordinates in 3D stereotactic space. Studies restricted to males/females or children/adults were included in the initial screening. Where data from an earlier study formed part of another study, the largest was selected. Initially, 23 VBM bipolar studies were found meeting our criteria (Bruno et al., [@B15]; Doris et al., [@B33]; Lochhead et al., [@B85]; Lyoo et al., [@B88]; McIntosh et al., [@B93]; Dickstein et al., [@B32]; Farrow et al., [@B41]; McDonald et al., [@B92]; Nugent et al., [@B100]; Adler et al., [@B1]; Chen et al., [@B19]; Yatham et al., [@B138]; Haldane et al., [@B53]; Janssen et al., [@B64]; Scherk et al., [@B108]; Almeida et al., [@B3]; Ha et al., [@B51]; Kempton et al., [@B73]; Stanfield et al., [@B116]; Li et al., [@B81]; Tost et al., [@B122]). However, three of these studies could not be included since they reported no gray matter volume differences between patients and controls (Bruno et al., [@B15]; McDonald et al., [@B92]; Scherk et al., [@B108]), and this cannot be accommodated in ALE. Two of the studies included comprised patients of bipolar type 1 and 2 (McIntosh et al., [@B93]; Ha et al., [@B51]), while all other studies reported patients with type 1 disorder. Four studies (McIntosh et al., [@B93]; Farrow et al., [@B41]; McDonald et al., [@B92]; Janssen et al., [@B64]) compared volumetric changes between bipolar and schizophrenia. Co-ordinates on bipolar disorder from three of these studies (McIntosh et al., [@B93]; Farrow et al., [@B41]; Janssen et al., [@B64]), were included in the analysis as one study only reported co-ordinates describing schizophrenia (McDonald et al., [@B92]).

Another search was conducted to look for "matching" studies which addressed schizophrenia. Because the majority of bipolar studies comprised patients who had an illness duration of over 5 years, and were medicated, the search extended to allow matching using the keywords: schizophrenia, chronic schizophrenia, psychosis, medicated, medication, MRI; found 54 schizophrenia studies (Wright et al., [@B134]; Hulshoff Pol et al., [@B61]; Paillere-Martinot et al., [@B102]; Sigmundsson et al., [@B114]; Wilke et al., [@B131]; Ananth et al., [@B5]; Job et al., [@B67]; Kubicki et al., [@B76]; Shapleske et al., [@B112]; Suzuki et al., [@B117]; Marcelis et al., [@B89]; Salgado-Pineda et al., [@B105], [@B106]; Ha et al., [@B52]; Moorhead et al., [@B98]; Antonova et al., [@B7]; Giuliani et al., [@B46]; Honea et al., [@B60]; Jayakumar et al., [@B65]; McDonald et al., [@B92]; Neckelmann et al., [@B99]; Ohnishi et al., [@B101]; Whitford et al., [@B130]; Bassitt et al., [@B10]; Chua et al., [@B20]; Douaud et al., [@B34]; Kasparek et al., [@B71], [@B70]; Kawasaki et al., [@B72]; Marti-Bonmati et al., [@B90]; Prasad et al., [@B104]; Schaufelberger et al., [@B107]; Tregellas et al., [@B123]; Yamada et al., [@B137]; Cooke et al., [@B24]; Garcia-Marti et al., [@B45]; Hirao et al., [@B58]; Koutsouleris et al., [@B74]; Meda et al., [@B95]; Meisenzahl et al., [@B96]; Venkatasubramanian et al., [@B129]; Wolf et al., [@B133]; Yoshihara et al., [@B139]; Benedetti et al., [@B11]; Euler et al., [@B40]; Herold et al., [@B57]; Lui et al., [@B86],[@B87]; Segall et al., [@B109]; Tomelleri et al., [@B121]; Witthaus et al., [@B132]; Xu et al., [@B136]). Of these studies, Antonova et al. ([@B7]), Cooke et al. ([@B24]), Farrow et al. ([@B41]), Giuliani et al. ([@B46]), and Janssen et al. ([@B64]) included patients with schizoaffective disorder.

One-to-one matching of studies
------------------------------

The guidelines followed for matching were as follows: 1)Bipolar and schizophrenia studies were matched by mean duration of illness and mean age of the patients2)If the duration of illness was not stated in the bipolar study, then the mean age of onset was matched3)If a VBM study already compared bipolar disorder and schizophrenia, then information from both the bipolar and schizophrenia aspects of the study would be included, essentially it was considered to be "self-matched"4)During matching, if there were two or more similar schizophrenia studies, the mean age of controls, number of patients, and number of controls were considered to obtain as close a match as possible.5)If the bipolar study comprised patients experiencing their first episode of illness, then the matching schizophrenia study also contained first episode patients.

First episode was so defined by the authors of the original studies included in the analysis (the longest mean duration of illness reported was 7 months). Five of the selected schizophrenia studies comprised patients with schizoaffective disorders (Antonova et al., [@B7]; Farrow et al., [@B41]; Giuliani et al., [@B46]; Cooke et al., [@B24]; Janssen et al., [@B64]) -- see Table [1](#T1){ref-type="table"}.

###### 

**Schizophrenia and bipolar disorder studies, paired for similar duration of illness, and age of patients**.

  Bipolar studies (Bi)                                        Schizophrenia studies (Sc)                                  Mean duration of illness (Bi/Sc) (years)             Mean age of patients (Bi/Sc) (years)   Mean age of controls (Bi/Sc) (years)   Sample size (Bi/Sc) (*n*)   Controls (Bi/Sc) (*n*)
  ----------------------------------------------------------- ----------------------------------------------------------- ---------------------------------------------------- -------------------------------------- -------------------------------------- --------------------------- ------------------------
  Adler et al. ([@B2])                                        Marcelis et al. ([@B89])                                    8.7/8.5                                              31.2/30.7                              30.5/35.5                              32/31                       27/27
  Adler et al. ([@B1])                                        Job et al. ([@B67])                                         FE/FE[^1^](#tfn1){ref-type="table-fn"}               19.9/21.4                              21.5/21.2                              33/34                       33/36
  Almeida et al. ([@B3])                                      Bassitt et al. ([@B10])                                     11.1/11.4                                            31.9/31.7                              30.8/35                                33/50                       33/30
  Chen et al. ([@B19])                                        Cooke et al. ([@B24])                                       14.2/13.9                                            38.2/38.4                              38.4/32.1                              24/52                       25/30
  Dickstein et al. ([@B32])                                   Yoshihara et al. ([@B139])                                  3.3/1.2                                              13.4/15.8                              13.3/15.8                              20/18                       20/18
  Doris et al. ([@B33])                                       Ananth et al. ([@B5])                                       16.2/15.8                                            38.1/37.8                              38.4/38.6                              11/20                       16/20
  Farrow et al. ([@B41])[^2^](#tfn2){ref-type="table-fn"}                                                                 FE/FE[^1^](#tfn1){ref-type="table-fn"}               17.5/19.7                              20.4                                   8/25                        22
  Ha et al. ([@B51])                                          Hirao et al. ([@B58])                                       10.4/10.6                                            35.6/36.7                              36/35                                  23/20                       23/20
  Haldane et al. ([@B53])                                     Ohnishi et al. ([@B101])                                    16.3/19.3                                            42.7/44.2                              43.1/40.3                              44/47                       44/76
  Janssen et al. ([@B64])[^2^](#tfn2){ref-type="table-fn"}                                                                FE/FE[^1^](#tfn1){ref-type="table-fn"}               15.4/16.5                              15.4                                   20/25                       51
  Kempton et al. ([@B73])                                     Cascella et al. ([@B17])[^3^](#tfn3){ref-type="table-fn"}   16.6/16.7                                            39.4/40.8                              35.2/46.3                              30/50                       52/90
  Li et al. ([@B81])                                          Venkatasubramanian ([@B128])                                3/3.4                                                28.4/30.1                              26.6/27.4                              24/30                       36/27
  Lochhead et al. ([@B85])                                    Benedetti et al. ([@B11])                                   24.3/24.8 yrs old[^4^](#tfn4){ref-type="table-fn"}   38.2/37.2                              36/35.1                                11/24                       31/20
  Lyoo et al. ([@B88])                                        Giuliani et al. ([@B46])                                    18.6/21.6 yrs old[^4^](#tfn4){ref-type="table-fn"}   38.3/39                                35.7/34.7                              39/41                       43/34
  McIntosh et al. ([@B93])[^2^](#tfn2){ref-type="table-fn"}                                                               n/a                                                  36.9/40.2                              35.3                                   45/26                       49
  Nugent et al. ([@B100])                                     McDonald et al. ([@B92])                                    23/17.4                                              41.2/37.3                              38/39.3                                20/25                       65/52
  Stanfield et al. ([@B116])                                  Tomelleri et al. ([@B121])                                  15.4/14.1                                            36.4/39.7                              39/40.3                                66/70                       66/79
  Tost et al. ([@B122])                                       Antonova et al. ([@B7])                                     15.9/16.8                                            42.4/40.5                              42.2/33.7                              42/45                       42/43
  Yatham et al. ([@B138])                                     Herold et al. ([@B57])                                      3.9/3.4                                              36/28.4                                36/27.4                                15/18                       15/21
                                                                                                                          Total:                                               32.7/33.2                              32.2/32.0                              540/651                     693/745

^1^*Both studies comprised patients experiencing their first episode (FE) of illness*.

^2^*Study was "self-matched" as it compared both bipolar disorder and schizophrenia*.

^3^*Whole schizophrenia group was used for comparison*.

^4^*Age of first onset used for matching*.

Conversion of co-ordinates to talairach space
---------------------------------------------

There were a total of 350 co-ordinates (184 for bipolar disorder, 166 for schizophrenia) extracted from the selected studies. Co-ordinates in Montreal Neurological Institute (MNI) format were transformed into the Talairach space (Talairach and Tournoux, [@B120]) using the "Lancaster transform," icbm2tal (Laird et al., [@B79]). Co-ordinates transformed to Talairach space using the 'Brett transformation', mni2tal, were transformed to the original MNI using mni2tal, and reconverted to Talairach using icbm2tal.

Dual disorder ale quantification
--------------------------------

By convention, ALE is performed to study a single disorder based on the paradigm that co-ordinates that are close in proximity will form resultant 3D clusters while distant co-ordinates will be filtered out. Consequently, resultant clusters in ALE should map to regions most consistently reported across studies for any given disorder. These regions theoretically hold greater biological importance than areas appearing in a single study only. This is achieved by first, extracting co-ordinates representing brain differences from voxel-based studies of the same disorder to generate a map of gray matter of differences A "permutation test" is used to examine whether each voxel on the likelihood map is statistically significant (Turkeltaub et al., [@B124]) in the whole brain. The threshold to define significance is determined by the false-discovery rate (FDR) technique (Laird et al., [@B78]). Finally, neighboring voxels that are identified as significant are clustered together, and the smaller clusters are filtered to avoid noise in the ALE result.

In the present study, a map of gray matter differences relative to controls was compiled for each individual study selected for inclusion, and smoothed with a kernel of 8 mm full width at half maximum (FWHM). Eight millimeter was used because we found it to have the best balance between false positive control and optimal cluster size (if too small, FWHM could generate non-representative "false positive" clusters, while if too large, it might limit anatomical resolution). The gray matter difference maps were then grouped according to their disorder type, and averaged into a mean map; thus, a mean map of bipolar and a mean map of schizophrenia were generated (see Figure [1](#F1){ref-type="fig"}). The mean maps were joined to create a total gray matter difference map, after which whole brain permutation testing (10,000 permutations) (Turkeltaub et al., [@B124]), and controlled FDR thresholding (*p* \< 0.05) (Laird et al., [@B78]) was conducted. Clusters greater than 100 mm^3^ were reported in the final ALE image (Laird et al., [@B77]). These steps were conducted using our in-house ALE kernel (Leung et al., [@B80]) derived from the open source software available at <http://csl.georgetown.edu/software/> (Turkeltaub et al., [@B124]). The "intensity" ratio of the mean disorder maps to the final ALE result at each resultant cluster was calculated. In all of the gray matter difference maps, the chance of finding gray matter differences was reflected by the voxel intensity. Suppose for a particular foci which has a voxel intensity of *x unit* in the mean bipolar difference map and *y unit* in the mean schizophrenia difference map, its corresponding intensity in the total gray matter difference map, and essentially the ALE result, would be *x* + y unit. The 'intensity' ratio of the bipolar difference map and the ALE result for that foci would be *x*:*x* + *y*, which gives an estimation of the contribution of bipolar studies to the final ALE result (ALE kernel and customized scripts for Matlab and SPM5 available from the authors of request). Thus, for a particular cluster, a higher percentage contribution from one disorder meant there was a higher chance that foci derived from that disorder were localized around that cluster. In contrast, an equal contribution of 50% would indicate an equal chance of finding foci from either disorder within the cluster. Two separate ALE analyses were conducted for lower gray matter volume and gray matter excess in bipolar disorder and schizophrenia.

![**Flow chart of dual disorder ALE quantification**.](fnhum-04-00189-g001){#F1}

Results
=======

Gray matter deficits
--------------------

There were 17 resultant ALE clusters. Both disorders showed lower gray matter in the bilateral frontal gyrus, thalamus, left middle temporal gyrus, cingulate gyrus, and caudate (near the caudate head). Gray matter volume lower in the left amygdala and insula was driven almost exclusively by schizophrenia studies (see Figure [2](#F2){ref-type="fig"} and Table [2](#T2){ref-type="table"}).

![**Cerebral gray matter volume deficits (top panel) and excess (bottom panel) in schizophrenia and bipolar disorder compared with healthy controls**. Blue clusters were driven mainly (greater than 80% distribution) by schizophrenia studies, while yellow were by bipolar studies. Green clusters were contributed by studies of both disorders (less than 80% distribution in either condition). Left side of brain is on left side of the panel.](fnhum-04-00189-g002){#F2}

###### 

**Percentage distribution of significant ALE clusters by disorder in reduced gray matter volume**.

  Cluster   Cluster center            Location                                Bipolar (%)   Schizophrenia (%)
  --------- ------------------------- --------------------------------------- ------------- -------------------
  1         (−44.47, 11.14, 0.59)     Left insula (BA 13)                     4.5           95.5
  2         (−16.81, −0.46, −18.49)   Left uncus/amygdala (BA 34)             4.6           95.4
  3         (−32.22, 15.18, −17.82)   Left inferior frontal gyrus (BA 47)     15.7          84.3
  4         (−2.92, −17.35, 8.04)     Thalamus (anterior nuclei)              15.9          84.1
  5         (−40.71, 20.99, 13.57)    Left inferior frontal gyrus (BA 45)     25.8          74.2
  6         (−51.89, 18.15, 5.69)     Left inferior frontal gyrus (BA 45)     35.4          64.6
  7         (−18.74, 51.59, 1.44)     Left superior frontal gyrus (BA 10)     39.9          60.1
  8         (−3.52, 8.65, −5.25)      Left caudate (caudate head)             53.8          46.2
  9         (43.1, 11.78, 4.8)        Right insula/precentral gyrus (BA 44)   55.2          44.8
  10        (−4.09, 45, 24.08)        Left medial frontal gyrus (BA 9)        60.8          39.2
  11        (−0.61, −1.7, 10.85)      Thalamus (medial dorsal nucleus)        62.2          37.8
  12        (−13.06, −22.62, 41.91)   Left cingulate gyrus (BA 31)            62.9          37.1
  13        (57.5, 9.82, 26.4)        Right inferior frontal gyrus (BA 9)     66.3          33.7
  14        (0.04, −7.61, 46.39)      Left paracentral lobule (BA 31)         69            31
  15        (10.81, −20.78, 46.29)    Right medial frontal gyrus (BA 6)       70.8          29.2
  16        (−57.54, 0.11, −21.2)     Left middle temporal gyrus (BA 21)      74.5          25.5
  17        (−40.2, 25.68, −4.74)     Left inferior frontal gyrus (BA 47)     74.8          25.2

Gray matter excess
------------------

There were six significant ALE clusters indicating gray matter excess in bipolar disorder and schizophrenia. Clusters with excess gray matter volume exclusively generated from bipolar disorder were identified in the tail of caudate bilaterally and right pre/post central gyrus. Volumetric enlargement of the left putamen were reported in both bipolar and schizophrenia studies. Larger left lentiform nucleus volume was also reported in schizophrenia, with larger left globus pallidus a feature of bipolar studies (see Figure [2](#F2){ref-type="fig"} and Table [3](#T3){ref-type="table"}).

###### 

**Percentage distribution of significant ALE clusters by disorder in enlarged gray matter volume**.

  Cluster   Cluster center            Location                                 Bipolar (%)   Schizophrenia (%)
  --------- ------------------------- ---------------------------------------- ------------- -------------------
  1         (−27.32, −2.97, 12.47)    Left lentiform nucleus                   12.8          87.2
  2         (−23.84, −7.92, −5.84)    Left putamen                             46            54
  3         (−8.29, −0.87, −1.95)     Left globus pallidus                     99.7          0.3
  4         (−11.21, −25.98, 22.26)   Left caudate (caudate tail)              100           0
  5         (12.83, −26.57, 22.13)    Right caudate (caudate tail)             100           0
  6         (40.45, −17.12, 28.54)    Right pre/post-central gyrus (BA4/BA6)   100           0

Discussion
==========

This study further develops the ALE approach to compare voxel-based brain-imaging data from studies of schizophrenia and bipolar disorder (Ellison-Wright and Bullmore, [@B38]). We did this to evaluate the extent to which the gray matter phenotype overlapped in these disorders. This helped address, at the neuroanatomical level, whether these disorders were more similar (continuous) or different (dichotomous) to each other. We found that in numerous regions gray matter volume was lower in both schizophrenia and bipolar disorder relative to neurotypical controls. The brain regions involved included bilateral frontal cortex, thalamus, left middle temporal gyrus, cingulate, and caudate. Schizophrenia studies almost exclusively generated additional clusters of lower gray matter volumes in the left hemisphere (including amygdala, and insula).

In this analysis, studies of schizophrenia were carefully selected to match those of bipolar disorder. The gray matter deficits in temporal, medial parietal, prefrontal, thalamus, caudate, and insula regions attributable to schizophrenia studies reported here, generally agree with those identified in previous meta-analyses of schizophrenia which had different sampling criteria (Ellison-Wright et al., [@B39]; Chan et al., [@B18]; Leung et al., [@B80]). In contrast, the literature on bipolar disorder has been much sparser. To the best of our knowledge, all the voxel-based studies of bipolar disorder reporting co-ordinates of gray matter volume differences relative to controls have been included in the meta-analysis. Every attempt was made to ensure that the schizophrenia studies were, as far as possible, balanced in terms of exposure to medication and duration of illness, since these have been reported to contribute to a lack of consistency between region-of-interest (ROI) and VBM studies (Giuliani et al., [@B46]). For example, the mood stabilizer lithium is known to have neurotrophic effects leading to gray cortical volume increase either after just 4 weeks (Moore et al., [@B97]) or more chronically (Silverstone et al., [@B115]). Not only lithium but also sodium valproate and carbamazepine are regarded as neuroprotective agents since they regulate numerous factors involved in cell survival pathways, including cyclic adenine monophospate response element-binding protein, brain-derived neurotrophic factor (BDNF), bcl-2, and mitogen-activated protein kinases (Bachmann et al., [@B9]). BDNF itself is necessary for neurotrophic signaling to regulate survival and function of neurons, synaptic plasticity and even the release of glutamate, GABA, dopamine, and serotonin (Du et al., [@B36]). However our analysis cannot speak directly to whether such neuroprotection is translated into the greater extent of gray matter excess in bipolar disorder observed in this analysis.

Findings from traditional ROI studies in schizophrenia fit reasonably well with our results and those from other ALE studies of schizophrenia. For example, there are reports of smaller amygdala (Joyal et al., [@B68]) and smaller insula (Crespo-Facorro et al., [@B26]; Kasai et al., [@B69]) in schizophrenia, although this is not always the case (for a fuller discussion see Leung et al., [@B80]). However, region of interest studies in bipolar disorder are more infrequent. Consistent with the present results, Drevets et al. ([@B35]) reported smaller anterior cingulate in bipolar disorder (Drevets et al., [@B35]), while in contrast to the present results, Altshuler et al. ([@B4]) reported that the amygdala is enlarged in bipolar disorder (Altshuler et al., [@B4]) and this finding was later supported by a ROI based meta-analysis(Arnone et al., [@B8]).

A number of past studies have directly compared schizophrenia and bipolar disorder. In general, gray matter deficits are more consistently reported in schizophrenia. Friedman et al. ([@B44]), found comparable deficits in schizophrenia and bipolar disorder (Friedman et al., [@B44]), but Lim et al. ([@B83]) reported that deficits were more pronounced in schizophrenia (Lim et al., [@B83]). Other investigations have found that gray matter deficits are selectively associated with schizophrenia not bipolar disorder (Harvey et al., [@B54]; Pearlson et al., [@B103]; Zipursky et al., [@B141]; Hirayasu et al., [@B59]; McDonald et al., [@B92]). In the intervening period, the advent of voxel-based techniques has expanded the literature on bipolar disorder. Our finding that gray matter deficits were rather more extensive in schizophrenia than bipolar disorder is in keeping with the classical observation that clinical prognosis for schizophrenia is better in the presence of affective symptoms. We generally concur with the previous study from Ellison-Wright and Bullmore ([@B38]) that gray matter deficits identified in bipolar disorder are more restricted in extent compared to schizophrenia. However we noted that gray matter deficits in anterior cingulate cortex, a component of the limbic system and reward-learning pathway, were present in both disorders and not only in bipolar disorder. In addition we were intrigued to find caudate head volumetric deficits in both disorders but caudate tail enlargement in the bipolar group; in contrast, Ellison-Wright and Bullmore\'s ([@B38]) reported overall caudate nucleus enlargement in the schizophrenia group only and other meticulous studies have shown no difference in caudate nucleus volume between patients with schizophrenia and healthy controls (Crespo-Facorro et al., [@B27]). The lower caudate volumes revealed in this study may be explained by the large number of first-episode studies included. In the schizophrenia literature, there is a reasonable consensus that caudate volumes are lower prior to drug treatment (Chua et al., [@B20]; Leung et al., [@B80]) but increase following even short periods of treatment (Chua et al., [@B21]; Deng et al., [@B31]).

Cincotta and Seger ([@B23]) have reported that the caudate nucleus shows functional dissociation, with the caudate head mainly responsible for feedback processing whereas the caudate body and tail is involved in stimulus-category learning. Since the caudate head is linked to the dorsolateral prefrontal cortex while the ventral caudate body and tail are linked to the extrastriate and visual infero-temporal cortex, there should be caudate dissociation between frontal-executive learning and visual processing (Seger and Cincotta, [@B110]). If so then caudate head lesions may impact on motivational and learning skills which are present in both schizophrenia and bipolar disorder. However, we still do not know whether functional dissociation translates into structural morphology, thus further work on the role of the caudate in psychosis is much needed.

Right insula volumes were lower in both patients with schizophrenia and bipolar disorder, whereas lower left insula volumes were largely associated with schizophrenia. This result agrees with a number of ROI studies observing lower insular volumes in the left hemisphere (Caligiuri et al., [@B16]) and bilaterally (Graybiel, [@B47]; Kasparek et al., [@B71]) in schizophrenia. In contrast, the volume of insular cortex has been reported as unchanged in bipolar illness (Takahashi et al., [@B118]), but negatively correlated with number of depressive episodes suffered by these patients (Takahashi et al., [@B119]). Our results indicate that lower insula volumes in the left hemisphere may be more a feature of schizophrenia, while right hemispheric insula differences are found in both schizophrenia and bipolar disorder. Thus volume deficit of the insula may be preferentially linked to psychosis which appears consistent with studies showing negative correlation between insular volumes and psychotic symptoms (Caligiuri et al., [@B16]; Corson et al., [@B25]; Hurlemann et al., [@B62]).

Although we noted bilaterally located deficits in the schizophrenia group, those which were almost exclusively pertinent to the disorder were left lateralized. There is evidence that left-sided pathology in schizophrenia starts early, as it is reported even in adolescent onset schizophrenia (Janssen et al., [@B64]). Moreover left-sided pathology in frontal and temporal lobes may be progressive (Kasai et al., [@B69]; van Haren et al., [@B125]). In Crow\'s ([@B29]) essay on schizophrenia, he recognized schizophrenia as a disorder affecting both hemispheres and constraining typical left lateralization of brain (Crow, [@B29]). A breakdown in the bi-hemispheric co-ordination of language is postulated to contribute to the nuclear symptoms of schizophrenia (Crow, [@B28],[@B29]; DeLisi et al., [@B30]), for example where disruption of communication between two hemispheres could be perceived as "voices" (Jaynes, [@B66]). The bi-hemispheric distribution of gray matter abnormalities in the studies reviewed fits the hypothesis that the processes driving asymmetry of the brain are interrupted in schizophrenia.

The current pattern of results therefore indicates that schizophrenia and bipolar disorders are not completely dichotomous entities at least at the level of neuroanatomical phenotype. This observation is necessarily simplistic, but lends further support to the argument that they share biological dimensions. It is compatible with Kraepelin\'s own qualification that it can sometimes be hard to stake out a firm diagnosis (Kraepelin, [@B75]). We welcome the renewed debate on diagnostic classification which can stimulate investigation of shared etiological mechanisms, and support the use of prognostic indicators and treatment targets relevant to both conditions. In terms of etiology, a recent very large scale study of families with members suffering from schizophrenia or bipolar disorder provided the strongest evidence to date that these disorders share a genetic basis (Lichtenstein et al., [@B82]). This agrees with accumulating evidence that schizophrenia and bipolar disorder have common susceptibility genes including 22q11, neuregulin 1, and transcription factor SP4 (Shifman et al., [@B113]; Green et al., [@B48]; Zhou et al., [@B140]). The disorders even have common prognostic indicators such as cognitive impairment (Green, [@B49]). The shared prefrontal cortical gray matter deficits observed here may well contribute to core common cognitive dysfunction leads to adverse effects on outcome in both disorders (Green, [@B49]).

Given these shared profiles, it is rather more challenging to explain why neuroanatomical differences are more extensive in schizophrenia than in bipolar disorder. Broadly speaking this could be a consequence of additional pathological mechanisms operating in schizophrenia, protective mechanisms at play in bipolar disorder, or some mixture of the two. The explanation for common and distinct neuroanatomy in schizophrenia and bipolar disorder is therefore likely to be complex. It is now better appreciated that even within one susceptibility gene such as DISC1 (Disrupted in schizophrenia 1), the risk of psychosis depends on one risk variant, in concert with other risk variants on the same gene (Hennah et al., [@B56]). The authors of this latter study concluded that "a new level of analysis is needed to take into account the stratification of genetic risk and the complexity of phenotypic association."

We acknowledge that our study has a number of methodological limitations. In general, studies reporting null results are less likely to be available and unfortunately, even if such information is accessible, ALE cannot accommodate "absent" foci. In addition, voxel-based methodology is continually being adapted and the data from original studies incorporated into our analysis most certainly had been preprocessed and analyzed in different ways (Fox et al., [@B43]; Honea et al., [@B60]; Laird et al., [@B78]; Ellison-Wright and Bullmore, [@B37]; Fornito et al., [@B42]). Unfortunately we did not have sufficient studies to control for such confounds as modulation and smoothing, and add our voice to the call for more "rigorous standards of data reporting" (Fox et al., [@B43]; Fornito et al., [@B42]).

In conclusion, we find that a synthesis of available data supports a number of shared neuroanatomical features of schizophrenia and bipolar disorder. This application of a technique which accommodates multiple studies in a relatively unbiased approach, serves to contribute additional information from neuroimaging research to the continuing debate on the Kraepelinian legacy. The results lend support to the proposition by van Os and Kapur ([@B126]) that in schizophrenia what is inherited is "altered brain development, shared partly with ......affective disorders."
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